La
oficina de proyectos
internacionales del IIS
Aragón ha creado este
boletín mensual mediante
el cual se va a informar
de las convocatorias de
proyectos que se
encuentran abiertas, los
eventos y las jornadas que
puedan resultar
interesantes al respecto
para el personal
investigador y de
gestión.
Si quieres contactar con
la oficina de proyectos
internacionales puedes
hacerlo a través de esta
dirección de correo
electrónico:
internacional@iisaragon.es
The
ISIDORe project
proposes to fund
Research &
Development into
preparedness and
responsiveness, by
giving scientific
communities, free-of-charge
transnational
access (TNA)
to the whole extent
of our
state-of-the-art
facilities,
cutting-edge
services, advanced
equipment and
technologies, made
available through
our catalogue of
services.
IARC
Summer School 2023
Call for
Applications is
Open
The
International Agency
for Research on
Cancer (IARC) is
pleased to announce
that it is now
accepting
applications for the
IARC Summer School
2023, for two
modules:
"Introduction to
Cancer Epidemiology"
and "Implementing
Cancer Prevention
and Early
Detection".
The IARC Summer
School 2023 provides
the opportunity to
stimulate cancer
research, improve
scientific
knowledge, and
develop
collaborations among
researchers
worldwide. Building
on past successful
IARC Summer Schools,
the two modules in
2023 will be
delivered as blended
training programmes,
combining online
learning with
virtual and
in-person classes.
The hybrid format
will offer the best
of remote learning
and the unmatched
value of
relationships formed
during face-to-face
events and their
effect on boosting
network-building and
future
collaborations.
Those who want to
attend the summer
school module on
"Implementing Cancer
Prevention and Early
Detection" should
first take the
self-paced course on
cancer prevention
and early detection,
which is available
on the IARC Learning
portal. This
self-paced learning
path will take
participants through
various resources,
which cover the
basic concepts and
principles related
to cancer prevention
and early detection.
See the links below
for more
information.
Horizon
Europe – ERC Proof
of Concept Grant
(ERC-2023-POC)
Horizon
Europe – ERC Proof
of Concept Grant
(ERC-2023-POC)
The ERC Proof of
Concept Grants aim
at facilitating
exploration of the
commercial and
social innovation
potential of ERC
funded research, by
funding further work
(i.e. activities
which were not
scheduled to be
funded by the
original ERC
frontier research
grant) to verify the
innovation potential
of ideas arising
from ERC funded
projects. Proof of
Concept Grants are
therefore on offer
only to Principal
Investigators whose
proposals draw
substantially on
their ERC funded
research.
The financial
contribution will be
awarded as a lump
sum of EUR 150 000
for a period of 18
months.
The ERC expects
that, normally,
proof of concept
activities should be
completed within 12
months. However, to
allow for those
projects that
require more
preparation time,
the grant agreements
will be signed for
18 months.
Extensions of the
duration of proof of
concept projects may
be granted only
exceptionally.The
lump sum will cover
the beneficiaries'
direct and indirect
eligible costs for
the project: if the
project is
implemented
properly, the
amounts will be paid
regardless of the
costs actually
incurred. The lump
sum has been
designed to cover
the beneficiaries’
personnel costs,
subcontracting,
purchase costs,
other cost
categories, and
indirect costs.
All Principal
Investigators in
an ongoing ERC
main grant or in a
ERC main grant
that has ended
less than 12
months before 1
January 2023,
are eligible to
apply for an ERC
Proof of Concept
Grant.
ATTRACT-Call:
Accelerate
Together Rare
Cancer Treatment
Cinco
fondos europeos
contra el cáncer,
entre los que se
encuentra la
Fundación Científica
de la Asociación
Española Contra el
Cáncer, se unen para
estimular la
investigación
internacional para
el desarrollo de
fármacos contra
cánceres raros.
Esta convocatoria
internacional
conjunta,
ATTRACT-Call, se
centra en ensayos
clínicos de fase 2/3
de medicamentos
contra cánceres
raros, y cuenta con
11,5 M€ de
presupuesto.
Objetivos:
- Mejorar el
tratamiento de los
cánceres raros
- Llevar los
fármacos a la
siguiente fase de
Desarrollo
Horizon
Europe – ERC
Consolidator Grant
(ERC-2023-COG)
The
ERC Consolidator
Grants are designed
to support excellent
Principal
Investigators at the
career stage at
which they may still
be consolidating
their own
independent research
team or programme.
Principal
Investigators must
demonstrate the
ground-breaking
nature, ambition and
feasibility of their
scientific proposal.
Consolidator Grants
may be awarded up to
a maximum of EUR
2 000 000
for a period of 5
years.
The maximum size of
the grants is
reduced pro rata
temporis for
projects of a
shorter duration.
(This does not apply
to ongoing
projects).
The Principal
Investigators shall
have been awarded
their first PhD at
least 7 and up to
12 years prior to
1 January 2023.
Cut-off dates: PhD
awarded from 1
January 2011 to 31
December 2015
(inclusive).
Convocatoria
de Proyectos
Transnacionales con
participación de la
Agencia Estatal de
Investigación en el
marco de “ERA4Health
Partnership”.
España participa en
la segunda
convocatoria
transnacional de la
iniciativa
ERA4Health
Partnership
“Fostering a
European Research
Area for Health”, a
través de la Agencia
Estatal de
Investigación (AEI),
el Instituto de
Salud Carlos III
(ISCIII) y la
Consejería de Salud
y Consumo de la
Junta de Andalucía
(CSCJA).
El objetivo general
de la convocatoria
es apoyar la
investigación
transversal que
contribuya al
desarrollo de
estrategias de
innovación
terapéutica en
enfermedades
cardiovasculares,
abordando alguna (o
ambas) de las
siguientes áreas de
investigación:
1- Reparación
y/o regeneración del
corazón y/o de los
vasos sanguíneos.
2-Insuficiencia
cardíaca crónica y
fibrilación
auricular.
Call
for Proposals 2023 :
«Natural History
Studies addressing
unmet needs in Rare
Diseases”
The objective of
this call is to
conduct efficient,
innovative and
high-quality natural
history studies
which will
facilitate
understanding of the
disease’s or group
of disorders’
progression
throughout the
lifespan of a
patient. The goal of
these studies is to
collect and analyze
comprehensive
patient data to
define targets for
future therapies,
taking into
consideration
innovation, safety,
and efficacy.
Research proposals
should cover at
least one of
the following areas:
1-
Estimation of
disease prevalence;
2- Identification
of
biomarkers/companions
for the
diagnosis/prognosis
of a RD;
3- Identification
of
biomarkers/indicators/predictors
of a rare disease or
group of disorders
(e.g. having the
same aetiology)
onset/progression
(including
collection of
genetic,
physiological,
environmental data
or variables….);
4- Identification
of relevant
endpoints for future
studies that include
potential
biomarkers, querying
patient-reported
outcomes (PROs) and
quality-of-life
measures;
5- Identification
of
biomarkers/variables
for therapeutic
approaches
(pharmacology, drug
repurposing, gene
therapy, RNA
therapy, cell
therapy, medical
devices…).
MSCA
COFUND co-finances
new or existing
doctoral programmes
and postdoctoral
fellowship schemes
with the aim of
spreading the best
practices of the
MSCA including
international,
inter-sectoral and
interdisciplinary
research training,
as well as
international and
cross-sectoral
mobility of
researchers at all
stages of their
career.
In practice, MSCA
COFUND provides
complementary
funding for doctoral
or postdoctoral
programmes managed
by entities
established in EU
Member States or
Horizon Europe
Associated
Countries. Those
co-funded programmes
must follow MSCA’s
good practice in
terms of
international
recruitment and
minimum standard of
employment for the
recruited fellows as
described in the
European Charter for
Researchers and Code
of Conduct for the
Recruitment of
Researchers.
Opening date:
11/10/2022
EU4H-2022-PJ-11:
Call for proposals
on prevention of
NCDs -
cardiovascular
diseases, diabetes
and other NCDs EU4H-2022-PJ-12:
Call for proposals
on cancer and other
NCDs prevention –
action on health
determinants EU4H-2022-PJ-14:
Call for proposals
to support the
roll-out of the
second cohort of the
inter-speciality
cancer training
programme
Call
for proposals for Mechanisms
of Resilience and
Vulnerability to
Environmental
Challenges in
Mental Health.
The aim of the call
is to facilitate
multinational,
collaborative
research projects
that will address
critical
translational
questions to improve
our knowledge
concerning
neurobiological
mechanisms involved
in resilience or
vulnerability to
environmental
challenges in mental
health.
(Call
opens 10 January
2023) AMR
Diagnostics and
Surveillance 2023
Proposals
should aim to
address unmet needs
in the AMR
diagnostics and
surveillance sectors
beyond the current
state of the art, by
focusing on one
of the topics
of the call:
• Topic 1: To
develop novel, or
improve existing,
diagnostics,
including point of
care diagnostics,
that can rule out
antimicrobial use or
help identify the
most effective
antimicrobial
treatment.
• Topic 2: To
develop or improve
existing strategies,
technologies or
methods, or data use
strategies to
support One Health
AMR surveillance.
MSCA
Staff Exchanges
promote innovative
international,
inter-sectoral and
interdisciplinary
collaboration in
research and
innovation through
exchanging staff and
sharing knowledge
and ideas at all
stages of the
innovation chain.
The scheme fosters a
shared culture of
research and
innovation that
welcomes and rewards
creativity and
entrepreneurship and
helps turn ideas
into innovative
products, services
or processes. It is
open to research,
technical,
administrative, and
managerial staff
supporting R&I
activities.
Horizon
Europe – Research
infrastructure
services to
support health
research,
accelerate the
green and digital
transformation,
and advance
frontier knowledge
(2023) (INFRASERV)
HORIZON-INFRA-2023-SERV-01-01:
Research
infrastructure
services to enable
R&I addressing
main challenges and
EU priorities.
For RI services for
improving clinical
research in the
paediatric area
• advancement of
paediatric medicines
and other
therapeutic and
diagnostic
approaches for this
population group to
markets and towards
clinical use;
• accelerated
availability of
solutions and
products to
paediatric patients
in need;
• wider access to
rationally designed
RI services across
Europe to underpin
the competitiveness
of the European
industry and of
biotech SMEs
developing
paediatric medicines
and treatment and
diagnostic devices;
• joining forces
of research
infrastructures and
paediatric
competence networks
in EU Member States
and Associated
Countries, to
facilitate
paediatric research
in the context of
pertinent EU
regulatory
environment;
• availability of
innovative tools to
conduct paediatric
clinical trials, for
the re-use of
population and
historical data, and
for enhanced data
sharing across
actors at different
care levels and
across regions in
Europe.
ERA4Health
Call for
transnational
research proposals “Increasing
health equity
through promoting
healthy diets and
physical activity
(HealthEquity)”
The aim of this call
is to develop novel
strategies and
targeted approaches
to identify,
understand, and
modify determinants
and mechanisms of
diet-related
behaviour and
physical activity as
well as sedentary
behaviour, which
have the potential
to break through the
cycles maintaining
unhealthy behaviours
and lifestyles and
to reduce health
inequalities.
The call will be
announced on 13/01/2023
and the submission
system will be open
on the same day.
•
HORIZON-JU-IHI-2022-03-01:
Screening platform
and biomarkers for
prediction and
prevention of
diseases of unmet
public health need
• HORIZON-JU-IHI-2022-03-02:
Patient-generated
evidence to improve
outcomes, support
decision making, and
accelerate
innovation
• HORIZON-JU-IHI-2022-03-03:
Combining hospital
interventional
approaches to
improve patient
outcomes and
increase hospital
efficiency
• HORIZON-JU-IHI-2022-03-04:
Strengthening the
European
translational
research ecosystem
for advanced therapy
medicinal products
(ATMPs) for rare
diseases
• HORIZON-JU-IHI-2022-03-05:
Digital health
technologies for the
prevention and
personalised
management of mental
disorders and their
long-term health
consequences.
Los consorcios
solicitantes deben
asegurarse de que al
menos un 45% del
presupuesto total
está cubierto por
las contribuciones
de los participantes
en el proyecto.
•
EU4H-2022-PJ-16:
Call for proposals
to support Member
States and other
relevant actors to
implement relevant
results of
innovative public
health research in
relation to
vaccination against
COVID-19.
•
HORIZON-MISS-2023-CANCER-01-01:
Addressing
poorly-understood
tumour-host
interactions to
enhance immune
system-centred
treatment and care
interventions in
childhood,
adolescent, adult
and elderly cancer
patients.
• HORIZON-MISS-2023-CANCER-01-02:
Enhance primary
cancer prevention
through sustainable
behavioural change.
• HORIZON-MISS-2023-CANCER-01-03:
Pragmatic clinical
trials on minimally
invasive diagnostics
• HORIZON-MISS-2023-CANCER-01-04:
Establish best
practices and tools
to improve the
quality of life for
childhood cancer
patients, survivors
and their families
in European regions.
• HORIZON-HLTH-2023-ENVHLTH-02-01:
Planetary health:
understanding the
links between
environmental
degradation and
health impacts.
• HORIZON-HLTH-2023-ENVHLTH-02-02:
Evidence-based
interventions for
promotion of mental
and physical health
in changing working
environments
(post-pandemic
workplaces)
• HORIZON-HLTH-2023-ENVHLTH-02-03:
Health impacts of
endocrine-disrupting
chemicals: bridging
science-policy gaps
by addressing
persistent
scientific
uncertainties.
• HORIZON-HLTH-2023-ENVHLTH-02-04:
Global coordination
of exposome
research.
• HORIZON-HLTH-2023-DISEASE-03-01:
Novel approaches for
palliative and
end-of-life care for
non-cancer patients.
• HORIZON-HLTH-2023-DISEASE-03-03:
Interventions in
city environments to
reduce risk of
non-communicable
disease (Global
Alliance for Chronic
Diseases – GACD)
• HORIZON-HLTH-2023-DISEASE-03-04:
Pandemic
preparedness and
response: Broad
spectrum anti-viral
therapeutics for
infectious diseases
with epidemic
potential.
• HORIZON-HLTH-2023-DISEASE-03-05:
Pandemic
preparedness and
response: Sustaining
established
coordination
mechanisms for
European adaptive
platforms trials
and/or for cohort
networks.
• HORIZON-HLTH-2023-DISEASE-03-06:
Towards structuring
brain health
research in Europe.
• HORIZON-HLTH-2023-DISEASE-03-07:
Relationship between
infections and
non-communicable
diseases.
• HORIZON-HLTH-2023-DISEASE-03-17:
Pandemic
preparedness and
response:
Understanding
vaccine
induced-immunity.
• HORIZON-HLTH-2023-DISEASE-03-18:
Pandemic
preparedness and
response:
Immunogenecity of
viral proteins of
viruses with
epidemic and
pandemic potential.
Ensuring
access to
innovative,
sustainable and
high-quality
health care
(Single stage
-2023) (HORIZON-HLTH-2023-CARE-04)
• HORIZON-HLTH-2023-TOOL-05-01:
Clinical trials of
combined Advance
Therapy Medicinal
Products (ATMPs)
• HORIZON-HLTH-2023-TOOL-05-03:
Integrated,
multi-scale
computational models
of patient
patho-physiology
(‘virtual twins’)
for personalised
disease management.
• HORIZON-HLTH-2023-TOOL-05-04:
Better integration
and use of
health-related
real-world and
research data,
including genomics,
for improved
clinical outcomes.
• HORIZON-HLTH-2023-TOOL-05-05:
Harnessing the
potential of
real-time data
analysis and secure
Point-of-Care
computing for the
benefit of
person-centred
health and care
delivery.
• HORIZON-HLTH-2023-TOOL-05-08:
Pandemic
preparedness and
response: in vitro
diagnostic devices
to tackle
cross-border health
threats.
• HORIZON-HLTH-2023-TOOL-05-09:
Developing a Data
Quality and Utility
Label for the
European Health Data
Space.
• HORIZON-HLTH-2023-IND-06-01:
Supporting the
uptake of innovative
Health Technology
Assessment (HTA)
methodology and
advancing HTA
expertise across EU.
• HORIZON-HLTH-2023-IND-06-02:
Expanding the
European Electronic
Health Record
exchange Format to
improve
interoperability
within the European
Health Data Space.
• HORIZON-HLTH-2023-IND-06-04:
Modelling and
simulation to
address regulatory
needs in the
development of
orphan and
paediatric
medicines.
• HORIZON-HLTH-2023-IND-06-05:
Mapping the hurdles
for the clinical
applications of
Advanced Therapy
Medicinal Products
(ATMPs).
• HORIZON-HLTH-2023-IND-06-07:
Development and
harmonisation of
methodologies for
assessing digital
health technologies
in Europe.
•
Topic
1: Expanding
translational
knowledge in
minipigs: a path to
reduce and replace
non-human primates
in non-clinical
safety assessment
• Topic
2:
Patient-centric
blood sample
collection to enable
decentralised
clinical trials and
improve access to
healthcare
Proyectos
multinacionales de
Investigación sobre
Aspectos Éticos,
Legales y Sociales
(ELSA) de la
Neurociencia.
Las propuestas de
investigación podrán
abordar, entre
otros, los
siguientes temas:
* Consecuencias del
desarrollo de los
métodos
neurocientíficos de
diagnóstico.
* Diagnóstico en
ausencia de opciones
de tratamiento;
interacciones entre
pacientes
socioculturalmente
diversos y el
personal sanitario;
acceso (equitativo)
a métodos novedosos
y caros; uso no
intencionado y/o uso
indebido).
* Aspectos de
investigación
clínica con
pacientes que
padecen enfermedades
neurológicas o
psiquiátricas.
* Tecnologías
inteligentes y
estrecha interacción
entre el ser humano
y la máquina.
* Biobancos de
tejidos neuronales.
* Utilización de
datos cerebrales;
intervenciones
cerebrales en
contextos jurídicos.
* Impacto de la
neurociencia moderna
en las cuestiones,
conceptos y teorías
filosóficas
tradicionales sobre
aspectos
fundamentales de la
naturaleza humana.
* Cambios sociales y
culturales inducidos
por el conocimiento
neurocientífico y su
aplicación.
* Investigación e
innovación
responsables en
neurotecnología y
neurociencia.
The
European Commission
announces that the Info
Day for the EU Missions
will be held as a virtual
event on Wednesday 17 and
Thursday 18 January 2023.
The Cancer
Mission session
will be held from
14.00-16.00 on Tuesday
17th January.
The Info Day will present
the new calls in the
Missions' part of the main
Work Programme 2023 under
Horizon Europe.
The sessions will give the
opportunity to prospective
applicants to learn more
about the funding options
on Missions through a
series of dedicated
sessions.
All recordings of the
event's sessions will be
made available on-line for
future reference.
The
aim of the IHI Call Days
is to provide potential
applicants with the
information they need to
put together a strong
proposal and give them the
opportunity to identify
and meet partners for
their consortia.
The main activities of the
Call Days will be as
follows:
• Info session on the
rules and procedures
• Info sessions on the
call topics
En
horario de 09:00 a 17:10
tendrá lugar el infoday
del clúster salud en
formato online.
Esta jornada informativa
tiene por objeto informar
a los candidatos
(potenciales) sobre los
temas incluidos en el
programa de trabajo del
Grupo 1 "Salud" de 2023.
Increasing
health equity through
promoting healthy diets
and physical activity –
“HealthEquity” – 10:00
Following the recent
pre-announcement of the
HealthEquity call on
research targeting health
inequalities through
promoting healthy diets
and physical activity,
ERA4Health invites all
potential project
applicants to an
information webinar.
In the webinar, the call
documents and guidelines
on how to apply for the
call will be presented.
ERA4Health will also
facilitate networking of
applicants.
For participation, please
register via the link
below, until Wednesday
January 18, 2023 EOB.
EJP
RD – European Joint
Programme on Rare Diseases
– 13-17/02/2023 12 :00 –
17 :00 Barcelona, Spain
Registration is now open
to the yearly 5-day course
on “Translational Medicine
Explained (TMex) ” on 13-17
February 2023 in
Barcelona. The
course is intended for
PhD/MD students, postdocs
and other young scientists
who are involved in
biomedical research and
want to learn more about
Translational Medicine.
The TMex (“Translational
Medicine Explained)”
Winter School consists of
an introductory e learning
(~12 hours student
investment time) followed
by a 5-day face-to-face
workshop. The course is
intended for PhD/MD
students in the second
half of their PhD and
postdocs who are involved
in biomedical research.
The full fee is of 650€.
Special discounted fees of
475€ applies for EATRIS
members and I2TRON
students, and of 250€ for
VHIR students and EUPATI
fellows.
There are only 30 seats,
so we recommend applying
early (first come, first
served). The
registration will close
when all seats have been
filled. You
will need to submit a
biosketch and a motivation
letter which will be
reviewed by a selection
committee.
Contacto
Instituto de Investigación
Sanitaria Aragón (IIS Aragón)
Centro de Investigación
Biomédica de Aragón (CIBA)
Avda. San Juan Bosco, nº 13.
50009 - Zaragoza
Tfno. +34 976 71 64 17 | +34 976
71 44 02
Recibes este boletín porque eres
miembro del IIS Aragón o porque
estás interesado en sus
actividades. Si no deseas
recibirlo, por favor, ponte en
contacto con internacional@iisaragon.es
para tramitar la baja de la
suscripción.
